Atara Biotherapeutics (LTS:0HIY) Change In Other Working Capital : $-124.2 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Atara Biotherapeutics Change In Other Working Capital?

Atara Biotherapeutics's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $-74.2 Mil. It means Atara Biotherapeutics's Other Working Capital declined by $74.2 Mil from Dec. 2024 to Mar. 2025 .

Atara Biotherapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-45.5 Mil. It means Atara Biotherapeutics's Other Working Capital declined by $45.5 Mil from Dec. 2023 to Dec. 2024 .

Atara Biotherapeutics Change In Other Working Capital Historical Data

The historical data trend for Atara Biotherapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Change In Other Working Capital Chart

Atara Biotherapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

61.19

32.74

-15.49

30.28

-45.53

Atara Biotherapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															4.45	-24.18	-0.75	-25.05	-74.20

Atara Biotherapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-124.2 Mil.

Atara Biotherapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (LTS:0HIY) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT20:Germany

Address

1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics Headlines

No Headlines